Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment

Published:2024-09 Issue: Volume: Page:108653
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Holmberg Carl-Jacob^ORCID,Zijlker Lisanne P.^ORCID,Katsarelias Dimitrios^ORCID,Huibers Anne E.,Wouters Michel W.J.M.,Schrage Yvonne,Reijers Sophie J.M.,van Thienen Johannes V.,Grünhagen Dirk J.,Martner Anna^ORCID,Nilsson Jonas A.,van Akkooi Alexander C.J.^ORCID,Ny Lars^ORCID,van Houdt Winan J.,Olofsson Bagge Roger^ORCID

Funder

Swedish Cancer Society

Swedish Research Council

Göteborg Medical Society

University of Gothenburg Wallenberg Centre for Molecular and Translational Medicine

Sahlgrenska University Hospital

Publisher

Elsevier BV

Reference3 articles.

1. The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: an interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial);Holmberg;Eur J Surg Oncol,2024

2. Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma;Kiffin;Eur J Surg Oncol,2021

3. A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma;Huang;Nat Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP